BACKGROUND: Hepatopancreatobiliary (HPB) and gastric oncologic operations are frequently performed at referral centers. Postoperatively, many patients experience care fragmentation, including readmission to "outside hospitals" (OSH), which is associated with increased mortality. Little is known about patient-level and hospital-level variables associated with this mortality difference. STUDY DESIGN: Patients undergoing HPB or gastric oncologic surgery were identified from select states within the Healthcare Cost and Utilization Project database (2006-2014). Follow-up was 90 days after discharge. Analyses used Kruskal-Wallis test, Youden index, and multilevel modeling at the hospital level. RESULTS: There were 7,536 patients readmitted within 90 days of HPB or gastric oncologic surgery to 636 hospitals; 28% of readmissions (n = 2,123) were to an OSH, where 90-day readmission mortality was significantly higher: 8.0% vs 5.4% (p < 0.01). Patients readmitted to an OSH lived farther from the index surgical hospital (median 24 miles vs 10 miles; p < 0.01) and were readmitted later (median 25 days after discharge vs 12; p < 0.01). These variables were not associated with readmission mortality. Surgical complications managed at an OSH were associated with greater readmission mortality: 8.4% vs 5.7% (p < 0.01). Hospitals with <100 annual HPB and gastric operations for benign or malignant indications had higher readmission mortality (6.4% vs 4.7%, p = 0.01), although this was not significant after risk-adjustment (p = 0.226). CONCLUSIONS: For readmissions after HPB and gastric oncologic surgery, travel distance and timing are major determinants of care fragmentation. However, these variables are not associated with mortality, nor is annual hospital surgical volume after risk-adjustment. This information could be used to determine safe sites of care for readmissions after HPB and gastric surgery. Further analysis is needed to explore the relationship between complications, the site of care, and readmission mortality.
BACKGROUND: Hepatopancreatobiliary (HPB) and gastric oncologic operations are frequently performed at referral centers. Postoperatively, many patients experience care fragmentation, including readmission to "outside hospitals" (OSH), which is associated with increased mortality. Little is known about patient-level and hospital-level variables associated with this mortality difference. STUDY DESIGN: Patients undergoing HPB or gastric oncologic surgery were identified from select states within the Healthcare Cost and Utilization Project database (2006-2014). Follow-up was 90 days after discharge. Analyses used Kruskal-Wallis test, Youden index, and multilevel modeling at the hospital level. RESULTS: There were 7,536 patients readmitted within 90 days of HPB or gastric oncologic surgery to 636 hospitals; 28% of readmissions (n = 2,123) were to an OSH, where 90-day readmission mortality was significantly higher: 8.0% vs 5.4% (p < 0.01). Patients readmitted to an OSH lived farther from the index surgical hospital (median 24 miles vs 10 miles; p < 0.01) and were readmitted later (median 25 days after discharge vs 12; p < 0.01). These variables were not associated with readmission mortality. Surgical complications managed at an OSH were associated with greater readmission mortality: 8.4% vs 5.7% (p < 0.01). Hospitals with <100 annual HPB and gastric operations for benign or malignant indications had higher readmission mortality (6.4% vs 4.7%, p = 0.01), although this was not significant after risk-adjustment (p = 0.226). CONCLUSIONS: For readmissions after HPB and gastric oncologic surgery, travel distance and timing are major determinants of care fragmentation. However, these variables are not associated with mortality, nor is annual hospital surgical volume after risk-adjustment. This information could be used to determine safe sites of care for readmissions after HPB and gastric surgery. Further analysis is needed to explore the relationship between complications, the site of care, and readmission mortality.
Authors: Eric B Schneider; Aslam Ejaz; Gaya Spolverato; Kenzo Hirose; Martin A Makary; Christopher L Wolfgang; Nita Ahuja; Matthew Weiss; Timothy M Pawlik Journal: J Gastrointest Surg Date: 2014-10-09 Impact factor: 3.452
Authors: Rony Takchi; Gregory A Williams; David Brauer; Tina Stoentcheva; Crystal Wolf; Brooke Van Anne; Cheryl Woolsey; William G Hawkins Journal: Am Surg Date: 2020-01-01 Impact factor: 1.002
Authors: Elizabeth M Hechenbleikner; Martin A Makary; Daniel V Samarov; Jennifer L Bennett; Susan L Gearhart; Jonathan E Efron; Elizabeth C Wick Journal: J Am Coll Surg Date: 2013-04-11 Impact factor: 6.113
Authors: David G Brauer; Sarah A Lyons; Matthew R Keller; Matthew G Mutch; Graham A Colditz; Sean C Glasgow Journal: Surgery Date: 2019-01-29 Impact factor: 3.982
Authors: Eric B Schneider; Omar Hyder; Christopher L Wolfgang; Kenzo Hirose; Michael A Choti; Martin A Makary; Joseph M Herman; John L Cameron; Timothy M Pawlik Journal: J Am Coll Surg Date: 2012-08-24 Impact factor: 6.113
Authors: Jeffrey J Tosoian; Caitlin W Hicks; John L Cameron; Vicente Valero; Frederic E Eckhauser; Kenzo Hirose; Martin A Makary; Timothy M Pawlik; Nita Ahuja; Matthew J Weiss; Christopher L Wolfgang Journal: JAMA Surg Date: 2015-02 Impact factor: 14.766
Authors: Donna Marie L Alvino; David C Chang; Joel T Adler; Abraham Noorbakhsh; Ginger Jin; John T Mullen Journal: Ann Surg Date: 2017-06 Impact factor: 12.969
Authors: S A R Nouraei; A Hudovsky; A E Frampton; U Mufti; N B White; C G Wathen; G S Sandhu; A Darzi Journal: Ann Surg Date: 2015-06 Impact factor: 12.969
Authors: Kristen E Rhodin; Vignesh Raman; Austin Eckhoff; Annie Liu; John Creasy; Daniel P Nussbaum; Dan G Blazer Journal: Ann Surg Oncol Date: 2022-06-20 Impact factor: 4.339